Skip to main content
NMD-VCell Research OSDisease state → cell state → target → experiment
SearchLaunch Workspace
View: Plain
Release 2026.08DMD context observedDMD candidate-conditioned prediction not yet eligible
View scientific status
Evidence freeze: 3 August 2026Resource: v1.2.0-measured-dmd-evidenceSchema: 1.1Open release status
Explore NMD-VCell

Gene evidence summary

ZFP69B

Current recommendation: Confirm that the gene is detectable.

What we know

ZFP69B was experimentally perturbed in HepG2 cells.

What remains uncertain

Different DMD datasets do not fully agree on the disease-associated direction. A matched perturbation in a DMD-relevant muscle model is the truth needed to calibrate a future DMD-response model.

What should happen next

Confirm that the gene is detectable. Use independent reagents and biological replication, and predeclare one functional endpoint.

Current value: this record identifies the most informative next experiment and the result needed for model calibration. It does not yet establish a therapeutic or clinical conclusion.

Design this experimentReview research evidenceCompare evidenceOpen core data

Evidence journey

Where ZFP69B stands—and what creates the next evidence

Read left to right from released knowledge to translation. The highlighted next step is a research decision, not a target score.

Inspect datasets and methods →
01 · Database supportVersioned gene recordStable identity, provenance and downloadable evidence are available.
02 · Disease contextDMD context assembledSource-specific DMD signals are retained separately for interpretation.
03 · Model evidenceCalibration truth neededThe current evidence defines what a future DMD-response model must learn and test.
04 · Experimental perturbationObserved outside DMD muscleThe HepG2 response is useful for context transfer, not yet DMD truth.
05 · Functional phenotypeNext decision experimentConfirm that the gene is detectable
06 · Clinical evidenceFuture translation layerClinical interpretation follows reproducible disease-matched functional evidence.

Data behind this summary

Exact values currently available for ZFP69B

These values come from different biological contexts and are displayed separately. They are not combined into one target score.

Open all dataset rows →
HepG2 perturbation coverage81 cellsCells in the frozen aggregate; not biological replicates.
Skeletal-muscle expression0.15521 TPMGTEx v8 tissue-expression context; not perturbation evidence.
DMD source effects2/3 directions agree3 source-specific effects retained without pooling.
Human-myoblast fusion screenNot assessedMissing is not a negative result.

What this candidate is for

Is ZFP69B detectably expressed at RNA and protein level in the intended human muscle model?

A candidate record authorizes a bounded question and next experiment. It does not authorize a therapeutic or clinical claim.

Practical useDecide whether a perturbation experiment would be technically interpretable.
Decision available nowExpression feasibility must be resolved before perturbation resources are committed.
What blocks itExpression feasibility is not verified in the intended model
Minimum next actionMeasure ZFP69B RNA and, where possible, protein in the intended myoblast or myotube state.
How would the result change the decision?

SupportiveMove to a bounded perturbation design if the frozen detectability threshold is met in independent biological replicates.

NullStop or redesign the assay if the target stays below the threshold; this does not establish no biological role.

Inconclusive / QC failureResolve assay specificity or state dependence if RNA, protein or replicates disagree.

Open Study CardPlan the experimentCompare decision gaps

Plain view presents the current story. Open Research for evidence details or Audit for machine fields and provenance.